openPR Logo
Press release

Alport Syndrome Treatment Market- Key Players |Abbott Laborites, Pfizer Inc., Novartis AG, Merck & Company, Inc., AstraZeneca plc., Johnson and Johnson, Eli Lilly and Company, Sanofi SA, Bayer AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd. a

03-13-2019 10:54 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Alport Syndrome Treatment Market- Key Players |Abbott

Alport Syndrome is the hereditary genetic disorder characterized by glomerulonephritis, abnormal vision, acute hearing loss and end-stage renal disease. Alport Syndrome is also called the hereditary nephritis. Alport syndrome is the rare disease usually affecting the male population. According to the National Institute of Health (NIH), alport syndrome occurs in approximately 1 in 50,000 newborns. People affected from alport syndrome experience progressive loss of kidney function.

Alport syndrome includes symptoms such as hematuria (blood in urine), high blood pressure, proteinuria (protein in the urine), edema (swelling in the legs, ankle, feet and around the eyes. Alport syndrome is basically caused by the mutation in COL4A3, COL4A4, and COL4A5. Mutation in these genes outcomes in abnormalities of the type IV collagen in glomeruli which restricts kidneys function to filter blood properly. About 80% of alport syndrome cases are caused by COL4A5 gene mutation and inherited in X linked pattern.

Approximately, 15%-20% alport syndrome results from COL4A3 and COL4A4 gene mutation. There is no definite medication existing for alport syndrome treatment. ACE inhibitors, angiotensin receptor blockers (ARB’s) and diuretic drugs are used for alport syndrome treatment. Angiotensin converting enzyme (ACE) inhibitor is the blood pressure medication given for alport syndrome treatment when the elevated level of protein is detected in the urine. ACE inhibitors inhibit the enzyme in the body from producing angiotensin II. ACE inhibitors such as benazepril, cilazapril, enalapril, fosinopril, quinapril, perinopril are used to treat alport syndrome treatment.

Request For Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1515

Alport Syndrome Treatment Market: Drivers and Restraints

The growing prevalence of the genetic disorder is expected to be the major factor driving the growth of the Alport syndrome treatment market over the forecast period. Increasing high blood pressure problems are secondary factors expected to boost the demand for alport syndrome treatment drugs.

Increasing the diagnosis rate due to screening programs, favorable medicare policies, increasing healthcare expenditures are another reason for the growth of the alport syndrome treatment market. Increasing research and development for the treatment of rare diseases is expected to boost the growth of alport syndrome treatment market. The side effect associated with some alport syndrome treatment medication and less awareness regarding diseases among the general population are some of the factors expected to restrain the growth of the alport syndrome treatment market.

Request For Brochure @ https://www.factmr.com/connectus/sample?flag=B&rep_id=1515

Alport Syndrome Treatment Market: Overview

The global market for Alport syndrome treatment is expected to witness moderate growth over the forecast period. Angiotensin converting enzyme (ACE) inhibitor is expected to contribute major revenue share in the alport syndrome treatment market. ACE inhibitor medication is most commonly used for alport syndrome treatment to reduce proteinuria and slow down the progression of kidney disorder.

Angiotensin receptor blockers are another drug given for alport syndrome treatment which restricts angiotensin II from binding to the corresponding receptors on blood vessels. Angiotensin receptor blockers are commonly used for individuals who do not respond to ACE inhibitors. ACE treatment therapy is for alport syndrome treatment is effective for people who have the small amount of albumin in the urine or proteinuria. Retail pharmacy distribution channel is expected to contribute high share in the global alport syndrome treatment market as it is the most accessible channel and the majority of patients are recommended for outpatient treatment.

Alport Syndrome Treatment Market: Regional Outlook

Geographically, the global Alport Syndrome Treatment market is segmented into viz. North America, Latin America, Europe, •CIS & Russia, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global alport syndrome treatment market owing to the high number of cases of alport syndrome and high healthcare facilities. Approximately 1 in 5,000-10,000 people in the United States are affected by alport syndrome. Europe is expected to have the second largest share in the global alport syndrome treatment market throughout the forecast period owing to increasing nephropathy practice and growing awareness related to the rare disease. The alport syndrome treatment market in the Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the increasing healthcare expenditure and growing healthcare facilities.

Alport Syndrome Treatment Market: Key Players

Examples of some of the key players operating in the global alport syndrome treatment market are Abbott Laborites, Pfizer Inc., Novartis AG, Merck & Company, Inc., AstraZeneca plc., Johnson and Johnson, Eli Lilly and Company, Sanofi SA, Bayer AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd. and others. As no treatment is available for alport syndrome treatment, companies are focusing on clinical trials for the development of alport syndrome treatment drugs which is expected to provide high growth opportunity for alport syndrome treatment market over the forecast period.

Report Analysis @ https://www.factmr.com/report/1515/alport-syndrome-treatment-market

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Read Industrial News : http://insiderstribune.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alport Syndrome Treatment Market- Key Players |Abbott Laborites, Pfizer Inc., Novartis AG, Merck & Company, Inc., AstraZeneca plc., Johnson and Johnson, Eli Lilly and Company, Sanofi SA, Bayer AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd. a here

News-ID: 1651069 • Views: 208

More Releases from Fact.MR

11-09-2020 | Health & Medicine
Fact.MR
PCR and Real-time PCR Molecular Diagnostics Market to Surpass US$ 6 Bn by 2030, …
As per data from the World Health Organization, millions of deaths can be attributed to diseases such as cancer and HIV each year. Further, the recent outbreak of the COVID-19 virus has also created massive demand for effective diagnostics processes. The PCR and real-time PCR molecular diagnostics market has been gaining traction in recent years on the back of investments by PCR diagnostic test manufacturers towards the incorporation of molecular
10-05-2020 | Health & Medicine
Fact.MR
Biobanking Market to Soar to US$ 3.5 Bn by 2027, Notes Fact.MR
Biobanks are a type of repository which is used in the storage of biological samples, including human and animal tissues, which primarily find use in research applications. Consequently, the process of biobanking has become a very important part of medical research and has played a major role in modern science fields such as personalized medications, and genomics. The global biobanking market is expected to grow at a healthy CAGR of ~
Mini LED Market to Expand 7.5X by 2030, Finds New Study by Fact.MR
In recent years, increasing popularity of OLED TVs in China and India has been significantly influencing growth of the mini LED market. With an increase in disposable income of a majority of the population in these countries, the inclination towards smart screens with higher lifespan and better performance is expected to open up numerous growth opportunities for the mini LED market. Moreover, aspiring and affluent households have increased their spending
Uncertainty Surrounding COVID-19 to Shave-off Growth in Electrical Steel Market …
The global electrical steel market has utilized the opportunities in the market over the last decade with sales of electrical steel pegged at US$ 20.4 Bn in 2019. However, sales are set to plummet during in the middle two quarters of 2020 owing to COVID-19. In addition, several automakers have shuttered their production units, causing incalculable loss to the electrical steel market in 2020. However, the demand of electrical steel

All 5 Releases


More Releases for Alport

Alport Syndrome Market 2020 (COVID-19 Impact Analysis) to Witness Excellent Grow …
An international Alport Syndrome Market report has been designed by keeping in mind the customer requirements which will ultimately assist them in boosting their return on investment (ROI). The business report also provides CAGR (compound annual growth rate) values along with its fluctuations for the specific forecast period. Explicit and state-of-the-art information have been given in this Alport Syndrome Market report which helps Healthcare industry to be knowledgeable about the
Alport Syndrome Market 2020 Projection By Top Key Players, Share, Size, Opportun …
The Alport Syndrome Market report puts forth an array of market insights which help with more precise understanding of the market landscape, issues that may impose on the industry in the future, and how to position specific brands in the best way. Today’s businesses call for greatly focused, widespread and detail-oriented market information so that the idea about the market landscape is absolutely clear. The Alport Syndrome Market research report
Alport Syndrome Market 2020 : Industry Size & Share, Business Strategies, Growth …
Global Alport Syndrome Market research report estimates a considerable growth of market in percentage during the forecast period of 2020-2026. This report also explains market definitions, classifications, applications, and engagements in the Healthcare industry. In addition, the scope of this market report can be broadened from market scenarios to comparative pricing between major players, cost & profit of the specified market regions. Alport Syndrome Market report is very consistent as
Global Alport Syndrome Market Pipeline Insight- Insight, Growth Rate and Forecas …
The Alport Syndrome Market Report Provides An Overview Of Therapeutic Pipeline Activity And Therapeutic Assessment Of The Products By Development Stage, Product Type, Route Of Administration, Molecule Type, And MOA Type For Alport Syndrome Across The Complete Product Development Cycle, Including All Clinical And Nonclinical Stages. A Better Understanding of Disease Pathogenesis Contributing To The Development Of Novel Therapeutics For Alport Syndrome. Get a sample copy of the report at-
Lipids Therapeutics-Pipeline Analysis 2018, Clinical Trials & Results | Variant …
Lipids are the large and miscellaneous group of organic compounds that are characterized by its solubility in non-polar solvents. There are various types of lipids, such as fatty acids, fats, oils, waxes, soaps and detergents, eicosanoids, terpenes, steroids, and phospholipids. Lipids play an important role in the various functions of the body, such as signaling, energy storage, biosynthesis of metabolites and hormones, degradation of toxic substances, and cell membrane formation. Download
Alport Syndrome Treatment Market Outlook & Deep Study of Top Consumers, Players …
Alport Syndrome is the hereditary genetic disorder characterized by glomerulonephritis, abnormal vision, acute hearing loss and end-stage renal disease. Alport Syndrome is also called the hereditary nephritis. Alport syndrome is the rare disease usually affecting the male population. According to the National Institute of Health (NIH), alport syndrome occurs in approximately 1 in 50,000 newborns. People affected from alport syndrome experience progressive loss of kidney function. Alport syndrome includes symptoms